{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:14:18Z","timestamp":1792120458570,"version":"4.4.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00236","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T14:07:35Z","timestamp":1562076455000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics"],"prefix":"10.3389","volume":"9","author":[{"given":"Kristin R.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mette","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne M\u00f8rck","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Franzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Guardabassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1128\/AAC.00537-16","article-title":"A high-throughput approach to identify compounds that impair envelope integrity in Escherichia coli","volume":"60","author":"Baker","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ijantimicag.2018.10.025","article-title":"Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators","volume":"53","author":"Baker","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1055\/s-2008-1067171","article-title":"Dimeric building blocks for solid-phase synthesis of \u03b1-peptide- \u03b2-peptoid chimeras","volume":"2008","author":"Bonke","year":"2008","journal-title":"Synthesis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd4675","article-title":"Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?","volume":"14","author":"Brown","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"18040","DOI":"10.3390\/ijms151018040","article-title":"Novel formulations for antimicrobial peptides","volume":"15","author":"Carmona-Ribeiro","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/j.1469-0691.2010.03162.x","article-title":"Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy","volume":"16","author":"Cerquetti","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.bbamem.2006.04.006","article-title":"Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action","volume":"1758","author":"Chan","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.resmic.2015.10.002","article-title":"Improved in vitro evaluation of novel antimicrobials: potential synergy between human plasma and antibacterial peptidomimetics, AMPs and antibiotics against human pathogenic bacteria","volume":"167","author":"Citterio","year":"2016","journal-title":"Res. Microbiol."},{"key":"B10","volume-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guidline","year":"1999"},{"key":"B11","volume-title":"Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard, 4th ed","year":"2013"},{"key":"B12","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing, 27th ed","year":"2017"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00200-17","article-title":"Potentiation of antibiotic activity by a novel cationic peptide: potency and spectrum of activity of SPR741","volume":"22","author":"Corbett","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0135961","DOI":"10.1371\/journal.pone.0135961","article-title":"In vivo, in vitro, and in silico characterization of peptoids as antimicrobial agents","volume":"11","author":"Czyzewski","year":"2016","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/cid\/ciw829","article-title":"Gram-negative bacterial infections: Research priorities, accomplishments, and future directions of the antibacterial resistance leadership group","volume":"64","author":"Doi","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00726-018-2673-9","article-title":"Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria","volume":"51","author":"Domalaon","year":"","journal-title":"Amino Acids"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e02374","DOI":"10.1128\/AAC.02374-17","article-title":"Short proline-rich lipopeptide potentiates minocycline and rifampin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa","volume":"62","author":"Domalaon","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","article-title":"Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing","volume":"20","author":"Ersoy","year":"2017","journal-title":"EBioMedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e41141","DOI":"10.1371\/journal.pone.0041141","article-title":"Guanidylation and tail effects in cationic antimicrobial lipopeptoids","volume":"7","author":"Findlay","year":"2012","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/9781555817435.ch5.12","article-title":"Synergism testing: broth microdilution checkerboard and broth macrodilution methods","volume-title":"Clinical Microbiology Procedures Handbook, 3rd Edition","author":"Garcia","year":"2010"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/cmdc.201500299","article-title":"Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides","volume":"10","author":"Ghosh","year":"2015","journal-title":"ChemMedChem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cbdd.12478","article-title":"Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens","volume":"85","author":"Gill","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1096\/fj.13-227942","article-title":"Sensitization of gram-negative bacteria by targeting the membrane potential","volume":"27","author":"Goldberg","year":"2013","journal-title":"FASEB J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e73620","DOI":"10.1371\/journal.pone.0073620","article-title":"Adaptive evolution of Escherichia coli to an \u03b1-peptide\/\u03b2-peptoid peptidomimetic induces stable resistance","volume":"8","author":"Hein-Kristensen","year":"2013","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2180-11-144","article-title":"Bacterial membrane activity of \u03b1-peptide\/\u03b2-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains","volume":"11","author":"Hein-Kristensen","year":"2011","journal-title":"BMC Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1021\/jm300820a","article-title":"Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones","volume":"55","author":"Jahnsen","year":"2012","journal-title":"J. Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1021\/jm401335p","article-title":"Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli","volume":"57","author":"Jahnsen","year":"2014","journal-title":"J. Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejpb.2015.01.013","article-title":"End group modification: efficient tool for improving activity of antimicrobial peptide analogues towards Gram-positive bacteria","volume":"95","author":"Jahnsen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9216","DOI":"10.1038\/srep09216","article-title":"Sensitization of gram-negative bacteria to rifampin and OAK combinations","volume":"5","author":"Jammal","year":"2015","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"42483","DOI":"10.1038\/srep42483","article-title":"The secondary resistome of pneumoniae","volume":"7","author":"Jana","year":"2017","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/S1462399410001766","article-title":"Antibiotic adjuvants: multicomponent anti-infective strategies","volume":"13","author":"Kalan","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1021\/acsmedchemlett.7b00200","article-title":"Synthetic antibacterial peptide exhibits synergy with oxacillin against MRSA","volume":"8","author":"Lainson","year":"2017","journal-title":"Med. Chem. Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens","volume":"2","author":"Lin","year":"2015","journal-title":"EBioMedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.2147\/IJN.S107107","article-title":"Novel antimicrobial peptide\u2013modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus","volume":"11","author":"Liu","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"B35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijantimicag.2012.09.014","article-title":"High in vitro antimicrobial activity of \u03b2-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis","volume":"41","author":"Liu","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1021\/acs.jmedchem.6b01742","article-title":"Amphiphilic tobramycin\u2013lysine conjugates sensitize multidrug resistant gram-negative bacteria to rifampicin and minocycline","volume":"60","author":"Lyu","year":"2017","journal-title":"J. Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1021\/acsinfecdis.7b00071","article-title":"The challenge of overcoming antibiotic resistance: an adjuvant approach?","volume":"3","author":"Melander","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/IDR.S49229","article-title":"Peptidomimetics as a new generation of antimicrobial agents: current progress","volume":"7","author":"M\u00e9ndez-Samperio","year":"2014","journal-title":"Infect. Drug Resist."},{"key":"B39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/ph8030366","article-title":"Peptides and peptidomimetics for antimicrobial drug design","volume":"8","author":"Mojsoska","year":"2015","journal-title":"Pharmaceuticals"},{"key":"B40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/cmdc.201600553","article-title":"Lysine-based \u03b1-peptide\/\u03b2-peptoid peptidomimetics: influence of hydrophobicity, fluorination, and distribution of cationic charge on antimicrobial activity and cytotoxicity","volume":"12","author":"Molchanova","year":"","journal-title":"ChemMedChem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/molecules22091430","article-title":"Advances in development of antimicrobial peptidomimetics as potential drugs","volume":"22","author":"Molchanova","year":"","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e00329","DOI":"10.1128\/AAC.00329-18","article-title":"Lipopeptide paenipeptin analogues potentiate clarithromycin and rifampin against carbapenem-resistant pathogens","volume":"62","author":"Moon","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cis.2017.01.005","article-title":"Delivery systems for antimicrobial peptides","volume":"242","author":"Nordstr\u00f6m","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0960-894X(02)00006-9","article-title":"Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa","volume":"12","author":"Renau","year":"2002","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1128\/AAC.00092-15","article-title":"Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to \u03b2-lactam antibiotics","volume":"59","author":"Ribeiro","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bcp.2017.01.003","article-title":"What is an \u201cideal\u201d antibiotic? discovery challenges and path forward","volume":"133","author":"Singh","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/jm501341h","article-title":"Lipidated \u03b1-peptide\/\u03b2-peptoid hybrids with potent anti-inflammatory activity","volume":"58","author":"Skovbakke","year":"2015","journal-title":"J. Med. Chem."},{"key":"B48","unstructured":"Global Priority List Of Antibiotic-Resistant Bacteria To Guide Research, Discovery, And Development Of New Antibiotics. World Health Organisation2017"},{"key":"B49","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/DDDT.S107195","article-title":"Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria","volume":"11","author":"Wu","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/jcm7070158","article-title":"Tobramycin-linked efflux pump inhibitor conjugates synergize fluoroquinolones, rifampicin and fosfomycin against multidrug-resistant Pseudomonas aeruginosa","volume":"7","author":"Yang","year":"2018","journal-title":"J. Clin. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1128\/AAC.00129-11","article-title":"Antiplasmodial properties of acyl-lysyl oligomers in culture and animal models of malaria","volume":"55","author":"Zaknoon","year":"2011","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T08:25:34Z","timestamp":1610180734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":51,"alternative-id":["10.3389\/fcimb.2019.00236"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00236","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"article-number":"236"}}